Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 3Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 1Overweight 1Neoplasms 1Metabolic Syndrome 1Inflammation 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyslipidemias 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Counseling 4Tirzepatide 2Nutrition Assessment 2Methods 2Megestrol Acetate 2Diet Therapy 2semaglutide 1Urine Specimen Collection 1Trehalase 1Tablets 1Resistance Training 1Psychology, Positive 1Progestins 1Patient Navigation 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Exercise 1Estrogen Replacement Therapy 1Educational Status 1Early Intervention, Educational 1Diet, Plant-Based 1Diet, Healthy 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Overweight × semaglutide × 1 year × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡